Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Digital Health & Informatics
Diversity, Equity and Inclusion
Health & Wellness
Opioids & Pain Management
Sterile Compounding
Favorite
Like
Facebook
Tweet
Print
Kelsey N. Waruszewski, PharmD
Poster(s):
(9-074) Real-World Insights on Biosimilar Conversion and Persistency Following Adalimumab Originator Product Formulary Exclusion in Treatment-Experienced Patients
Wednesday, December 11, 2024
8:30 AM - 9:30 AM